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ABSTRACT A random population of temperature-sensitive
mutants was screened by assaying for defects in DNA synthesis in
a permeabilized yeast DNA replication system. Twenty mutants
defective in in vitro DNA synthesis have been isolated. In this pa-
per we describe eight of these mutants. Seven of them fall into
three complementation groups-cdc2, cdc8, and cdcl6-involved
in the control of the cell-division cycle. Because synthesis in vitro
represents propagation of replication forks active in vivo at the
time of permeabilization, our finding that cdc2 and cdcl6 mutants
can incorporate dTMP into DNA in such permeabilized cells at
23'C but not at 37C supports the conclusion that these two muta-
tions directly affect DNA synthesis at replication forks. Such an
involvement was previously suggested by n vimo analysis for CDC2
but was less clear for CDC16. Finally, the usefulness of our
screening procedure is demonstrated by the isolation of replica-
tion mutants in previously undescribed complementation groups.
One strain shows a serious defect in in vivo DNA synthesis but
normal RNA synthesis.
Attention has focused recently on the microbial eukaryote, Sac-
charomyces cerevisiae, in which both genetic and biochemical
approaches to the study of gene expression are possible. Our
interest in the yeast system is related to the ability to take a
combined genetic and biochemical approach to the study of DNA
replication. Specifically, we would like to isolate and charac-
terize the proteins required for DNA replication in yeast by
complementation of DNA replication mutants in a cell-free in
vitro DNA replication system such as has recently been de-
scribed (1-4).
Genetic analysis of yeast DNA replication began with the
isolation and characterization of a number of temperature-sen-
sitive mutants having defects in cell division (5). Of these, sev-
eral were found to be deficient in DNA synthesis (cdc28, cdc4,
cdc7, cdc2, cdc6, cdc8, cdc2l, and cdc9) (5-11). The products
of CDC28 and CDC4 are believed to have execution points in
the cell cycle before the actual onset of DNA synthesis, and
CDC7 seems to act at the time of entry into S phase (7, 9). CDC21
has been shown to be defective in the synthesis of dTMP (12).
Thus only CDC2, CDC6, CDC8, and CDC9 appear to be di-
rectly involved in DNA synthesis. CDC2 must function to com-
plete DNA synthesis, and CDC6 seems to be involved in ini-
tiation (8). CDC8 has been shown to be involved in elongation
and is required for mitochondrial DNA synthesis (7, 13). Re-
cently, the CDC8 protein was purified and shown to bind to
single-stranded DNA (14, 15). cdc9 mutants synthesize DNA
at the nonpermissive temperature, but the DNA is of low mo-
lecular weight. cdc9 strains contain no DNA ligase, and there-
fore CDC9 may be the structural gene for ligase (11).
It is likely that a considerable number of additional genes are
involved. Johnston and Thomas (16) have isolated seven tem-
perature-sensitive mutants that show a reproducible decrease
in DNA synthesis at the nonpermissive temperature, but spe-
cific defects have not been elucidated. Dumas et al. (17) have
described a screening procedure for identifying mutants de-
fective in incorporation of [3H]uracil into DNA in vivo. They
have defined 60 complementation groups, many of which are
likely to play direct roles in DNA synthesis. We have adopted
a different approach that consists of screening a randomly mu-
tagenized population of conditionally lethal yeast strains for de-
fects in replication in vitro. The in vitro assay uses yeast cells
made permeable to nucleoside triphosphates with the deter-
gent Brij 58 (15, 18, 19). Such a screening procedure has the
advantage that every one of the mutants identified probably
has a lesion in a gene directly involved in DNA synthesis. Twenty
mutants have been identified. Three fall in previously iden-
tified cdc complementation groups, but 14 have not been pre-
viously identified. Here we report results pertaining to CDC2
and to CDC16, cell cycle mutants whose in vivo phenotype did
not previously allow one to conclude whether or not these mu-
tants had a specific defect in DNA synthesis.
MATERIALS AND METHODS
Strains. The parent strain A364a (a adel ural gall tyri his7
lys2) and a strain derived from A364, strain 198, cdc8-1 were
from L. H. Hartwell (University of Washington) (20). Strain
cdc7 was derived from A364 and was from John Scott (Uni-
versity of Illinois). The 400 haploid temperature-sensitive mu-
tants, which do not form colonies at 360C but do form colonies
at 230C, were derived from A364a by mutagenesis with N-meth-
yl-N'-nitro-N-nitrosoguanidine by L. H. Hartwell (5, 20) and
were provided by Fred Sherman (University of Rochester). Strain
D273-lla (a adel hisi trp2) was from the Cold Spring Harbor
Laboratory collection. Strains of a mating type for comple-
mentation studies, obtained by crossing each mutant with strain
SRG05-1 (a trpl-l met8-1 ile-l ilv-2) were from Steve Reed
(University of California, Santa Barbara). Segregants of a mat-
ing type were identified using standard test strains.
Media. YPD medium, SD medium, sporulation agar, YPDG,
and minimal agar are described in ref. 21.
Genetic Procedures. Complementation testing was per-
formed by cross-streaking haploid strains of known genotype
on YPD plates. After incubation overnight, the strains were
replicated on appropriate synthetic medium (to select for auxo-
trophic markers) and then incubated at 370C.
Standard procedures for genetic crosses in yeast were used,
and all crosses were performed on YPD agar. Sporulated cells
were removed from sporulation agar and suspended in H20.
Asci were digested for 20 min at 320C with a 1:20 dilution of
glusulase. Tetrads were dissected and analyzed.
Preparation of Permeabilized Cells. Strains were grown at
230C to a density of 2 x 107 cells per ml in YPD medium, col-
lected by centrifugation, and washed twice with H20. The cells
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were suspended in 10 mM Tris-HCl, pH 7.2/2 M sucrose/1%
Brij 58 to a final concentration of 2 X 108 cells per ml and in-
cubated until the cells were permeable as monitored by alkaline
phosphatase activity (18). The permeabilized cells can be frozen
at -200C for up to 2 wk and used in the assay for DNA synthesis
when desired.
Screening Assay for DNA Synthesis. The standard DNA
replication reaction mixture contained 50mM Tris HCl (pH 8.0);
10mM MgCl2; 1.5mM 2-mercaptoethanol; 50 AM dATP, dGTP,
and dCTP; 2 1LM [a-32P]dTTP (4,000-8,000 cpm/pmol); 1 mM
ATP; 10 mM phosphoenolpyruvate; 1% Brij 58; 0.05 ml of
Tris-HCl/sucrose/Brij 58 cell suspension. After incubation for
30 min at 370C the reaction was stopped and the amount of ra-
dioactive material was determined as described (15).
Labeling of DNA and RNA with [3H]Adenine. Mutants
showing a defect in DNA synthesis in the above procedure were
assayed for DNA synthesis in vivo. Cells were grown in YPD
medium at 230C to 2 X 107 cells per ml. YPD medium was re-
moved by centrifugation and washing and cells were suspended
in SD medium containing the required amino acids (30 ,ug/ml)
and [3H]adenine at 7 ,Ci/ml (1 Ci = 3.7 X 1010 Bq) to a con-
centration of 5 X 107 cells per ml. After 30 min at 23°C, an ali-
quot of the cell suspension was removed. Cell number was de-
termined and the amount of [3H]adenine incorporated into DNA
and RNA was measured as described in ref. 5. The remaining
culture was then maintained at 37°C with shaking. After 3 hr,
another sample was taken to determine cell number and ra-
dioactivity incorporated into DNA and RNA as described in ref.
5.
RESULTS
Characterization of DNA Synthesis in Permeabilized Cells.
Hereford and Hartwell (18) showed that yeast cells made
permeable by the addition of Brij 58 can incorporate [a-32P]dTTP
into DNA in a reaction requiring Mg2+, ATP, and the three other
dNTPs. Although cells of the mutant cdc4 gave normal syn-
thesis in the permeable cells when grown at the permissive
temperature, synthesis did not occur in permeabilized cdc4
mutants that had been kept at the nonpermissive temperature
for more than one generation time before permeabilization. Be-
cause cdc4 mutants are capable of completing an ongoing round
of replication at the nonpermissive temperature but are incapa-
ble of initiating new synthesis (6), this result suggested that
synthesis in vitro represented the propagation of replication
forks active in vivo at the time of permeabilization. When per-
meabilized cells were prepared from cdc8 mutants, which are
deficient in elongation, no in vitro synthesis was observed
whether the cells were grown at permissive or nonpermissive
temperatures (18), suggesting that the same machinery used in
vivo for carrying out DNA replication was also used in vitro.
A modification of the permeabilization procedure that was
developed by Banks for studying Ustilago has been described
(15, 19). Cells are made permeable to triphosphates by incu-
bation in sucrose/Brij 58. By using this system, we were able
to reproduce the results obtained by Hereford and Hartwell
(18) and to extend them in several ways as described in ref. 15.
In Fig. 1, we present an additional aspect of this system-
namely, that initiation mutants behave in the sucrose/Brij 58-
treated cells in the same way that they do in the Brij 58-treated
cells described by Hereford and Hartwell (18). Cells were grown
at 230C, incubated with Tris-HCl/sucrose/Brij 58 at 300C for
the indicated times, and synthesis was measured at 37°C. Fig.
1 reveals that wild-type cells respond to treatment with deter-
gent and incorporate dTMP into DNA. In strain cdc8, however,
even after several hours of treatment, there is no incorporation
at 37TC. cdc7 mutants are defective in the initiation of DNA
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FIG. 1. Optimum time of Brij 58 treatment. Cells were treated
with Brij 58 for the times indicated. Synthesis was then measured at
3700. Values represent extent of synthesis and not initial rate (15). ts
154, temperature-sensitive mutant strain 154.
synthesis at 37C in vivo (6-8) and behave quite differently from
cdc8 strains in vitro. The cdc7 mutant incorporates dTMP into
DNA at 370C to the same extent as wild type. In a separate ex-
periment, cdc4 responded exactly as cdc7. Thus, mutants that
inhibit entrance into S phase are not defective in synthesis in
this type of in vitro system when the cells are grown at the per-
missive temperature. Only if they are incubated at the non-
permissive temperature in vivo for several hours do they show
an in vitro defect (data not shown; see also ref. 19).
We also compared the amount of in vitro synthesis at 23TC
and 37TC in strains A364a (wild type), cdc7, and cdc8. At 230C
synthesis is approximately the same in all three strains (Table
1). However, at 37TC synthesis is increased in wild type and in
cdc7 relative to 230C, but it is decreased to background level
in cdc8. Thus, cdc8 replication is thermolabile in vitro, re-
flecting exactly the response of cdc8 cells in vivo, but the cdc7
mutant is not defective at any temperature in vitro.
Detection of DNA Replication Mutants. Because the prep-
aration of permeabilized cells is easy and rapid, this in vitro
replication system seemed to offer an efficient means of screen-
ing directly for mutants with defects specifically affecting DNA
synthesis. The principle advantage of an in vitro system over
a screening procedure using in vivo labeling techniques is that
the latter cannot differentiate between mutants with a primary
defect in replication and those mutants in which the defect in
DNA synthesis is only secondary to a mutation affecting RNA
Table 1. Incorporation of [a-32P]dTMP in permeabilized mutants,
cdc7 and cdc8, and in the parental yeast strain A364a
dTMP incorpo-
rated per 108
cells, pmol
Strain 370C 230C
A364a 4.83 4.25
cdc7 5.02 4.76
cdc8 1.07 3.98
Strains were grown, harvested, treated with Tris-HCl/sucrose/Bri
58, and assayed. DNA synthesis was measured at 370C and 2300. cdc7
is temperature sensitive for the initiation ofDNA synthesis, and cdc8
is temperature sensitive for DNA replication at the restrictive tem-
perature (370C).
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synthesis, protein synthesis, or a cell-cycle function such as a
process required for the cells to enter S phase (for instance, cdc28,
cdc4, or cdc7).
Approximately 400 temperature-sensitive mutants, strains
ts92-ts492, were screened for a defect in DNA synthesis. The
mutants were grown at 230C and were harvested in logarithmic
phase of growth. The cells were washed, permeabilized by
treatment with Brij 58, and DNA synthesis was measured at
37TC. A strain was regarded as a potential DNA synthesis mu-
tant if it had <25% of the activity of wild type, because that
meant that it was as defective as (or more defective than) cdc8.
By this assay, 20 mutant strains showed a reproducible defect
in DNA synthesis, and the results obtained for seven of these
are shown in Table 2. The identification of such a large number
of replication mutants confirms that such mutants appear fre-
quently enough among heavily mutagenized populations (see
below) of conditional mutants to make screening for them by
in vitro replication assays a reasonable approach.
Identification of cdc8, cdc2, and cdc16 Alleles Among Our
Mutants. The mutant population we used was obtained from L.
H. Hartwell, who had already shown that it was a representa-
tive collection (see ref. 20). This collection had previously been
screened for cell-cycle mutants by assessing terminal pheno-
types by time-lapse photomicroscopy (20). Therefore, it was
possible to determine whether any of the temperature-sensi-
tive mutants that we had identified corresponded to any cdc
complementation groups, by comparing the numbers of our
mutants with those identified by Hartwell and colleagues. First,
we found that strain 198 was a cdc8 allele. This turned out to
be the same mutant we had used in the control experiments.
This finding established the reliability of the screen. Second,
two of our other mutants, strains 346 and 370, were found by
this comparison to be cdc2 mutants. Third, mutant strain 281
was found to be cdc16. There are a number of other mutants
belonging to the cdc2Z cdc8, and cdc16 complementation groups
in this collection. Mutants 256 and 336 (cdc2), 141 (cdc8), and
486 (cdc16) were either missing from the collection we received
or were no longer temperature sensitive in vivo and were there-
fore not assayed. Mutant 172 (cdc8) could not be permeabilized
with Brij 58. Mutant 284 (cdc16) showed less than 1/3rd the
level of wild-type synthesis in the first screen and was indeed
found to be even more defective than cdc8 when reassayed.
Mutants 246 and 249 (cdc16) were not as defective, but we have
not checked that our isolates actually contain cdc16 alleles. None
of our remaining 16 mutants was among those identified by
Table 2. DNA synthesis in some representative temperature-
sensitive mutants
DNA
Strain synthesis
A364a 1.00
cdc8 0.25
129 0.16
154 0.08
198 0.29
281 0.20
328 0.24
370 0.10
346 0.15
426 0.14
DNA synthesis was measured as the amount of [a-32P]dTMP incor-
porated into DNA at 370C. Values are the mean of at least three sep-
arate determinations. All reaction mixtures were adjusted to contain
approximately the same number of cells at the same stage of perme-
ability. All values are normalized to a value of 1.00 for A364a.
Hartwell and colleagues by screening for terminal phenotype
(20).
The finding that cdc2 and cdc16 mutants are defective in in
vitro synthesis was a surprising and interesting result, because
previous studies had not indicated clearly whether these mu-
tations directly affected DNA synthesis. Both mutants, for in-
stance, incorporate substantial amounts of radioactive precur-
sors into DNA at the nonpermissive temperature in vivo (22).
After discovering that these mutants were defective at 370C in
permeabilized in vitro systems, it was of interest to further
characterize them by testing for defects at 230C. We compared
the amount of synthesis in permeabilized cdc2 and cdc16 at 230C
and 37TC. Both mutants showed almost wild-type levels of in-
corporation in permeabilized cells at 23TC. Therefore, as for
cdc8, synthesis in vitro in these mutants is thermolabile. Thus
our results suggest strongly that both cdc2 and cdc16 genes are
directly involved in DNA synthesis.
Complementation Analysis. We were interested in knowing
how many complementation groups were represented among
our mutants. Complementation analysis was carried out by pre-
paring an a-mating type derivative of each of the 20- mutants.
Pairwise matings were then conducted as described, and the
resulting diploids were tested for temperature sensitivity. Mu-
tants 129, 328, and 426 were found to fall into the same com-
plementation group as 346 and 370-namely cdc2. Because of
the high frequency of appearance of mutations in the cdc2 group,
these mutants were chosen for further study. Strain 154 was in
a different complementation group from the others. It was cho-
sen for further study because it had a severe defect in in vitro
synthesis at both 230C and 370C, although more synthesis was
observed at 23TC. The remaining mutants have not been fur-
ther characterized and will be described elsewhere.
Cell-cycle theory predicts that a cdc gene product is nec-
essary for only one of the discontinuous events in the cell cycle
(20). Therefore one expects that at the nonpermissive temper-
ature an asynchronous culture of a conditional mutant in a cdc
gene will arrest growth with a homogeneous and characteristic
morphology called a terminal phenotype. The three cdc2 mu-
tants identified, strains 129, 328, and 426, do not show the typ-
ical arrest morphology (two large buds) of the two previously
identified cdc2 alleles, strains 346 and 370 (10). It is possible,
therefore, that these mutants contain secondary mutations and
that when they are removed the typical cdc2 terminal phe-
notype will be observed.
Segregation Analysis. It was also important in evaluating the
usefulness of this method of detecting replication mutants to
ensure that the temperature-sensitive phenotype and the de-
fect in in vitro DNA synthesis were due to mutations in the
same genes. Mutant strains 346 and 154 were each crossed with
an appropriate nontemperature-sensitive strain and sporulated,
and the segregation of the two traits, temperature sensitivity
in vivo and in vitro, was assayed in six tetrads for each cross.
In every tetrad, an example of which is shown in Table 3, the
temperature-sensitive phenotype and the in vitro defect seg-
regated together. This 2:2 pattern of ts-/ts' (temperature sen-
sitive/not temperature sensitive) indicates that the tempera-
ture-sensitive in vitro synthesis is due to a mutation in a single
gene and that the same mutation is responsible for both the in
vivo and in vitro thermolability.
DNA Synthesis in Vivo in the Recently Identified Repli-
cation Mutants. To verify that the new mutants actually had
defects in DNA replication, the ability of mutant 154 to in-
corporate radioactive precursors into DNA and RNA in vivo
was measured. At the permissive temperature all strains, wild-
type A364a, cdc8, and mutant 154 showed similar levels of in-
corporation of [3Hladenine into DNA. The incorporation into
Biochemistry: Kuo et al.
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Table 3. Tetrad data and in vitro DNA synthesis in the spores
from crosses between temperature-sensitive mutants and
wild-type strain
Temperature
Spores sensitivity
154
la
lb
lc
ld
2a
2b
2c
2d
346
la
lb
lc
ld
ts-
ts-
ts+
ts+
t8+
ts+
ts-
ts-
ts+
ts+
ts-
ts-
DNA
synthesis
0.26
0.35
0.82
0.94
0.86
0.82
0.34
0.22
0.82
0.83
0.24
0.23
Strains were crossed with the wild-type strain D273-11a. The re-
sulting diploid cells were removed and six tetrads from each cross were
dissected. Each spore was analyzed for temperature sensitivity in vivo
and in vitro. Assay for temperature sensitivity was carried out by in-
cubating strains at 370C. Procedures for DNA synthesis are as de-
scribed in legend to Table 1. Data for only three representative tetrads
are presented. All 12 tetrads were the same, that is 6 for strain 154 and
6 for strain 346. ts+ indicates ability to grow at 3700; ts- indicates in-
ability to grow at 370.
DNA and RNA at the nonpermissive temperature, however,
was different in each of the mutants. These results are shown
in Table 4. With respect to DNA synthesis, cdc8 showed =25%
of the level of wild type. Mutant 154 was even more defective
than cdc8, showing only 15% of wild-type level. Both cdc8 and
mutant 154, however, showed a substantial amount of RNA
synthesis, 44% and 33%, respectively, of the wild-type level
and more than twice as much RNA synthesis as DNA synthesis.
Thus, strain 154 is in fact a previously unidentified DNA rep-
lication mutant, confirming that the in vitro screen detects mu-
tants with in vivo defects.
Further Characteristics of the Permeabilized Cell Screen-
ing System. One possible limitation of this screening method
is that mutations affecting initiation may escape detection.
However, one class of mutant we found, the cdc2 mutants, has
a phenotype consistent with a defect in initiation (23). There-
fore, the system may be more versatile than we would have pre-
dicted. Furthermore, initiation mutants are defective if grown
at the nonpermissive temperature, which could be incorpo-
rated into the screening procedure if desired (18).
A further consideration is whether chromosomal replication
is affected in the mutants identified. Yeast contains, in addition
to 16 (or 17) chromosomes, mitochondrial, ribosomal, and plas-
Table 4. DNA and RNA synthesis
Macromolecule
synthesis
Mutant RNA DNA
cdc8 0.44 0.24
Strain 154 0.33 0.15
RNA and DNA synthesis were measured as the amount of [3H]ad-
enine incorporated into RNA and DNA after 3 hr at 370C as described
(5). The absolute amount of 3H incorporated into each of the mutant
cultures was multiplied by the A5s0/A5s0 ratio of A364a vs. mutant at
the time of the shift to 370C and then divided by the amount of incor-
poration in a culture ofA364a. Thus, all values are normalized to a value
of 1.0 for A364a.
Table 5. DNA synthesis in some representative permeabilized p+
and p0 temperature-sensitive mutants
DNA synthesis
Mutant strain p + p9
96 0.72 0.29
145 0.83 0.62
282 0.60 0.25
346 0.16 0.20
Strains were grown, harvested, treated with Brij 58, and assayed for
DNA synthesis in vitro at 370C. DNA synthesis values are normalized
to a value of 1.0 for A364a. To isolate mutants containing no mito-
chondrial DNA, strains were grown for 4 days on YPD agar plates con-
taining ethidium bromide. p- phenotypes, cells that have no mito-
chondrial function, were identified and p- were distinguished from p0
by colony hybridization (24) using nick-translated yeast mitochondrial
DNA prepared as described by Zeman and Lusena (25).
mid DNAs. The work of Banks (19) suggested that Tris HCl/
sucrose/Brij 58-treated cells might carry out only mitochon-
drial synthesis, because in a p+ cell, all of the newly synthe-
sized DNA was of mitochondrial rather than chromosomal den-
sity. To ensure that the in vitro system was capable of measuring
chromosomal DNA synthesis and hoping to be able to screen
for genes affecting only chromosomal DNA synthesis, we pre-
pared p0 derivatives of each of the strains in the collection of
400 temperature-sensitive mutants. p0 strains contain no mi-
tochondrial DNA. When we assayed them for DNA synthesis
in vitro, we found about 50% as much synthesis on the average
in the mitochondrial-lacking mutants in this in vitro system (Table
5). The important point to emphasize is that although some of
the in vitro synthesis may be due to mitochondrial DNA, not
all of it is, because many p0 mutants are as efficient as wild type
at in vitro synthesis (Table 5). Unfortunately, because of the
inability to obtain reproducible results even on the same p0 strains
from experiment to experiment (Table 5 and data not shown),
it was not possible to correlate lack of synthesis in any particular
p° strain in vitro with specific mutations and we could not use
p strains to screen specifically for nuclear DNA synthesis de-
fects. We attribute the variability in permeabilized p0 to either
(i) a lower permeability than p+ cells; (ii) the fact that p0 cells
are much smaller (petites) than wild type and may, therefore,
be unable to transport enough precursors to support the full
level of synthesis; or (iii) increased variability in recovery of
cells during the harvesting procedure. The strongest evidence,
however, that chromosomal DNA synthesis is being observed
in vitro and that mutants in chromosomal synthesis can be de-
tected by the method described in this paper is the fact that
cdc2 mutants were among the mutants we identified. Conrad
and Newlon (23) have shown that mitochondrial DNA synthesis
continues for several hours after chromosomal DNA synthesis
has ceased at the nonpermissive temperature in vivo in cdc2
mutants. Because cdc2 mutants are deficient in vitro, we must
be observing defects due to chromosomal DNA synthesis.
DISCUSSION
We have examined 400 temperature-sensitive yeast strains for
mutants specifically defective in DNA replication by assaying
for replication in vitro using cells made permeable to nucleo-
side triphosphates by the nonionic detergent Brij 58. We have
identified 20 DNA replication mutants, 14 of which fall into
new complementation groups. We can thus conclude that rep-
lication mutants appear quite frequently among random con-
ditionally lethal mutant populations.
The reliability of the screening procedure was first dem-
onstrated by the fact that strain 198, previously shown to carry
Q A6468 Biochemistry: Kuo et al.
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cdc8-1 and demonstrated to have a DNA elongation defect, was
among the strains identified as having a replication defect in the
in vitro screen. Second, complementation analysis showed that
many different genes could be identified by this assay. The ef-
fectiveness of the screen was further demonstrated by confirm-
ing that strain 154, one of the recently identified mutants, had
a defect in DNA synthesis in vivo and that the in vitro repli-
cation defect cosegregated with the in vivo temperature-sen-
sitive growth phenotype in genetic crosses. It should be easy
to adapt this assay into a mass screening protocol, as has been
done in E. coli (26), now that the effectiveness of the permea-
bilized cells has been demonstrated.
One unexpected and interesting outcome of these studies
was the demonstration that cdc2 and cdc16 mutants are defec-
tive in DNA synthesis in this type of in vitro replication system.
cdc16 mutants arrest synthesis with a terminal phenotype like
that of other replication mutants, such as cdc8. In vivo, how-
ever, cdc16 does not show a drastic decrease in the amount of
incorporation of [3H]uracil into alkali-resistant material at the
nonpermissive temperature (5). Our results suggest that this
mutant probably does have a defect in DNA synthesis itself and
is worthy of further study.
cdc2 mutants have been shown to have an execution point
early in S phase (10, 22) and arrest with a morphology like that
of cdc8 at the restrictive temperature (20). The original results
of analysis of DNA synthesis in cdc2 mutants showed that cdc2
mutants incorporate substantial amounts of nucleic acid pre-
cursors at the nonpermissive temperature in vivo. Later it was
found, quite unexpectedly, that cdc2 cells remain sensitive to
hydroxyurea, an inhibitor of DNA synthesis, after incubation
at the restrictive temperature (8). To account for these two ap-
parently contradictory findings, it was suggested that the gene
product is required for the completion of DNA synthesis during
S phase. Our in vitro results would not have been expected on
the basis of the early in vivo incorporation studies but are en-
tirely consistent with the hydroxyurea experiments, supporting
the above explanation for the apparently contradictory results.
Recently, Conrad and Newlon have shown that 1/3rd of the
DNA remains unreplicated at the nonpermissive temperature
in cdc2 strains (23). It is not clear whether this is due to lack
of initiation at some replicons or inhibition of elongation. The
finding we report here, that cdc2 mutants are defective in an
in vitro replication system that clearly mimics in vivo repli-
cation, thus adds to the accumulating evidence that the product
of the CDC2 gene plays an important role in DNA synthesis in
yeast.
Because the in vitro system can identify DNA synthesis mu-
tants that do not show a substantial defect in precursor uptake
into DNA in vivo, this method of isolating mutants is an es-
sential complement to the in vivo screening procedure recently
described by Dumas et al. (17). As might have been expected,
cdc2 and cdc16 mutants were not among the alleles identified
in that study.
We originally used a complementation assay based on the
same permeabilized cell procedure used in this report to par-
tially purify the CDC8 protein. However, none of the other
mutants we have detected could be complemented in this sys-
tem, probably because of the limited permeability of the cells
to macromolecules. Recently, we have developed a fully sol-
uble in vitro replication system (4). We have been able to use
this system to purify the CDC8 protein to homogeneity by an
in vitro complementation assay. In vitro replication extracts have
been prepared from strain 154 and cdc2 and both are mrarkedly
defective in in vitro replication. The CDC2 protein and the strain
154 protein have already been purified by complementation
assay.
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